Article Dans Une Revue Clinical Infectious Diseases Année : 2010

Pegylated Interferon‐α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation

Résumé

This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.

Fichier non déposé

Dates et versions

hal-05096142 , version 1 (03-06-2025)

Identifiants

Citer

Nassim Kamar, Lionel Rostaing, Florence Abravanel, Cyril Garrouste, Laure Esposito, et al.. Pegylated Interferon‐α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation. Clinical Infectious Diseases, 2010, 50 (5), pp.e30-e33. ⟨10.1086/650488⟩. ⟨hal-05096142⟩
34 Consultations
0 Téléchargements

Altmetric

Partager

  • More